During the past decade, Hangzhou Third Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hangzhou Third Hospital" are "Atopic Dermatitis" (4 trials), "Acne Vulgaris" (1 trials), "Dermatitis, Atopic" (1 trials) and "Vitiligo" (1 trials). Many other conditions were trialed in "Hangzhou Third Hospital" in a lesser frequency.

Most popular intervention types in "Hangzhou Third Hospital" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Vehicle" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials) and "Crisaborole 2%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hangzhou Third Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Hangzhou Third Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hangzhou Third Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hangzhou Third Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Hangzhou Third Hospital has several departments that took part in Clinical trials: "Zhejiang Provincial People's Hospital/Dermatology Department" - 3 trials